Sign In
Buy DVAX
$15.50
+0 (+0%)
At Close: May 08, 2026
Why Dynavax, Novavax, and Sorrento Soared This Week
06:01am, Friday, 13'th Aug 2021
There were different reasons behind each of these COVID-19 vaccine stocks' big gains.
Former Penny Stocks To Watch After Merck's (MRK) Latest FDA Win
01:02pm, Thursday, 12'th Aug 2021
Merck's FDA and coronavirus vaccine news sparked momentum in biotech stocks today. Here are 4 to watch.
Hot Biotech Stocks That Deserve Your Attention In August 2021
11:56am, Wednesday, 11'th Aug 2021
Is it time to add biotech stocks to your list this year? The post Hot Biotech Stocks That Deserve Your Attention In August 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | Pen
Why COVID Vaccine Stocks Moderna, BioNTech, Novavax, and Dynavax Soared This Week
05:58am, Friday, 06'th Aug 2021
Each vaccine stock had its own separate catalyst.
Are Penny Stocks Worth It? 5 That Deserve Your Attention Now
12:36pm, Thursday, 05'th Aug 2021
Have penny stocks presented some of the biggest opportunities in the stock market? The post Are Penny Stocks Worth It?
Dynavax Technologies Corporation (DVAX) CEO Ryan Spencer on Q2 2021 Results - Earnings Call Transcript
09:31pm, Wednesday, 04'th Aug 2021
Dynavax Technologies Corporation (DVAX) CEO Ryan Spencer on Q2 2021 Results - Earnings Call Transcript
Dynavax Technologies (DVAX) Q2 Earnings and Revenues Top Estimates
07:50pm, Wednesday, 04'th Aug 2021
Dynavax Technologies (DVAX) delivered earnings and revenue surprises of 150.00% and 19.82%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Dynavax: Earnings This Year Ought To Surprise To The Upside
12:05pm, Sunday, 01'st Aug 2021
Dynavax earned $83.3m in Q121 - up >650% year-on-year. The uplift was largely due to its vaccine adjuvant, CPG-1018, which is being used by multiple COVID vaccine developers.
Dynavax to Report Second Quarter 2021 Financial Results and Host Conference Call on August 4, 2021
04:02pm, Wednesday, 21'st Jul 2021
EMERYVILLE, Calif. , July 21, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, will report se
Why Dynavax Stock Has Jumped 11% So Far This Week
06:01am, Friday, 02'nd Jul 2021
The company inked a significant supply deal for its vaccine adjuvant.
Clover, Dynavax Ink Commercial Supply Agreement For CpG 1018 Adjuvant
11:04am, Wednesday, 30'th Jun 2021
Clover Biopharmaceuticals and Dynavax Technologies Corporation (NASDAQ: DVAX) have executed the commercial supply agreement of Dynavax's CpG 1018TM advanced adjuvant for use in Clover's protein-b
Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate
07:00am, Wednesday, 30'th Jun 2021
CHENGDU, China, and EMERYVILLE, Calif., June 30, 2021 /PRNewswire/ -- Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeut
Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate
04:00am, Wednesday, 30'th Jun 2021
Clover to procure CpG 1018 adjuvant from Dynavax for use in the commercial production of Clover's COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum) Pending conditional regulatory approvals, Clover
Why COVID Vaccine Stocks Dynavax, Novavax, and Vaxart Are Sinking Today
11:50am, Tuesday, 15'th Jun 2021
The declines appear to be caused simply by volatility that's common with small biotech stocks.
Dynavax to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
04:05pm, Wednesday, 09'th Jun 2021
EMERYVILLE, Calif., June 9, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced
